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SUMMARY
Considering that there are some studies with autopsies from AIDS describing only malignant neoplasias and that changes can occur 
after the introduction of Highly Active Antiretroviral Therapy (HAART), our objectives were to analyze the frequency of benign and 
malignant neoplasms in AIDS patients in the periods of both pre- and post-HAART. This is a retrospective study with 261 autopsies 
of HIV-positive patients between 1989 and 2008 in Uberaba, Brazil. Sixty-six neoplasms were found (39 benign, 21 malignant and 
six premalignant) in 58 patients. The most frequent malignant neoplasms were lymphoid, in 2.7% (four Non-Hodgkin lymphoma, 
one Hodgkin, one multiple myeloma and one plasmablastic plasmacytoma), and Kaposi`s Sarcoma, in 2.3% (six cases). The most 
frequent benign neoplasms were hepatic hemangiomas in 11 (4.2%) of 261 cases and uterine leiomyoma in 11 (15.7%) of 70 woman. 
In the pre-HAART period eight (9.8%) benign neoplasias and four (4.9%) malignant occurred in 82 patients; in the post-HAART 
period, 29 (16.2%) benign and 17 (9.5%) malignant were present; however, the differences were not significant. We conclude that 
the introduction of HAART in our region doesn’t look to have modified the frequency of neoplasms occurring in patients with HIV.
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INTRODUCTION
The human immunodeficiency virus (HIV) infection is associated 
with the progressive deterioration in cell immunity that culminates 
in acquired immunodeficiency syndrome (AIDS). The decline in cell 
immunity explains two complications in patients with AIDS: infections 
and neoplasia2.
Kaposi’s sarcoma (KS), Non-Hodgkin lymphoma (NHL) and 
carcinoma of the uterine cervix are the most frequent neoplasms 
in AIDS patients. These are considered to be defining diseases for 
AIDS6,10,16,18. According to some authors, other types of neoplasia also 
seem to be more common among HIV-positive individuals. Among these 
types are: squamous cell carcinoma of the head/neck and anal region, 
plasmacytoma, melanoma, small cell lung cancer, basal cell carcinoma, 
Hodgkin’s lymphoma (HL) and germinative tumors5,9,11,13,30,34. The 
neoplasms associated with AIDS occur more frequently in developed 
rather than in underdeveloped countries12,23. LUCAS et al.26 described 
seven cases of B-cell NHL (2.8%) among 247 necropsies on HIV-positive 
patients in Africa and commented that the rarity of this tumor in this 
continent is associated with the short survival rate of African patients.
Antiretroviral therapy has given rise to changes in the morbidity 
and mortality rates among HIV patients. In addition to reducing the 
occurrence of opportunistic infections, it has also affected the occurrence 
of neoplasms that are correlated with AIDS20,24,28. Some studies have 
shown decreases in KS and primary NHL of the central nervous system 
(CNS) and less significant decreases in systemic NHL17. On the other 
hand, other studies have not demonstrated any change in the frequency 
of KS, and slight increases in the frequencies of NHL, HL and different 
types of carcinoma4,5,20,24,28. The occurrence of neoplasia of the uterine 
cervix has not undergone any significant change since the use of highly 
active antiretroviral therapy8,15.
Studies with large numbers of necropsies on AIDS patients in 
the literature have described overall findings relating to infections 
and neoplasms, giving greater emphasis to infections and malignant 
tumors. The frequency of malignant neoplasms is generally less than 
20%1,20,21,24,31,33,35. In Brazil, there are two reports on the frequency of 
malignant neoplasia in autopsied AIDS patients: BORGES et al.7 found 
five (9.6%) cases in 52 necropsies and CURY et al.12 identified three 
(3.3%) in 92 necropsies. However, we didn’t find works describing benign 
neoplasms in necropsies of patients with HIV infection.
We decided therefore, to evaluate the necropsies of HIV positive 
patients performed in a teaching hospital in Brazil between 1989 and 
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2008 (261 consecutive cases), describing all benign and malignant 
neoplasms, in an attempt to evaluate the prevalence of malignancies 
in AIDS patients in our country and see if some benign neoplasia 
would come into contact with HIV infection. For comparison, we 
used the prevalence of malignant neoplasia in other studies of HIV 
positive patients and for the benign neoplasia we used the prevalence 
among the general population, since we didn’t find studies describing 
benign tumors associated with HIV infection. We also compared the 
frequency of neoplasms before and after the introduction of highly 
active antiretroviral therapy (HAART).
MATERIAL AND METHODS
This was a retrospective study on necropsies performed on HIV 
positive patients at the University Hospital in Uberaba, Minas Gerais, 
Brazil, between January 1989 and December 2008. Over this period, 
1,785 necropsies were carried out, of which 261 (14.6%) were on patients 
who had been found to be serologically positive for HIV. There were no 
cases of the congenital transmission of HIV.
The neoplasias were described in relation to the benign or malignant 
type, sex and age of the patients. The cases were separated in two groups 
according to the date of necropsy if before or after the introduction of 
HAART (before or after 1997 in Uberaba, respectively), in order to 
assess whether there had been any increase or decrease in the number 
of neoplasia occurrences with the use of this medication.
We revised slides of all the tumors; usually slides are done from every 
organ including the uterine cervix in all necropsies; we microscopically 
analyzed the penis when injuries appeared on the macroscopy view. The 
classification of the tumors were done on a histological basis and when 
necessary with immunohistochemical analyses (leukocyte common 
antigen, CD20, CD3, desmin, actin 1A4, Myo D1, myogenin, CD38, 
CD79a, Kappa, Lambda, cytokeratin AE1/AE3, epithelial membrane 
antigen, carcinoembryonic antigen, HMB-45 and protein S-100).
The data relating to neoplasia frequencies before and after the 
introduction of HAART were analyzed using the X2 test or Fisher’s exact 
test. The mean ages in the total HIV group and HIV with neoplasia group 
were compared using Student’s t- test or Mann-Whitney test. Differences 
were taken to be significant when the p-value was less than 0.05. The 
procedures in the present study were in accordance with and approved 
by the local committee of ethics in research. 
RESULTS
Out of the 261 necropsies performed on HIV positive patients, 191 
(73.2%) were male. The mean age was 35.3 ± 10.7 years, ranging from 16 
to 69 years. Neoplasias were found in 58 (22.2%) of the 261 necropsies. 
Table 1 presents benign and malignant neoplasias in relation to age and 
sex. There tended to be a common occurrence of patients with neoplasms 
which were older than the total HIV group (p = 0.0176), females with 
neoplasms older than the female HIV group (p = 0.0221) and of female 
patients with malignant neoplasms which were older than females with 
benign neoplasms (p = 0.0493).
In the 58 HIV patients with neoplasia, 66 tumors were detected, 
of which 39 were benign, 21 malignant and six intraepithelial [one 
cervical intraepithelial neoplasia (CIN) grade I, two CIN II, one in situ 
carcinoma of glans and two condylomas of the penis]. Eight patients had 
two neoplasms: two patients with two benign neoplasias and six with one 
benign and one malignant neoplasia. Tables 2 and 3 summarize the data 
Table 1
Comparison between the total HIV group and the HIV with neoplasia group in relation to sex and age
HIV n
Age
mean (±) minimum maximum
Total HIV group 261 35.3 10.7 16 69
Male 191 35.6 11 16 69
Female 70 34.7 9.9 20 62
HIV with neoplasm 58 38.5 11.1 16 65
Male 36 37.4 12.3 16 65
Female 22 40.2 9.1 21 56
HIV with benign neoplasm 37* 39.9 9.2 24 65
Male 20 38.4 10.8 24 65
Female 17 41.6 6.9 33 56
HIV with malignant neoplasm 21* 36.5 12 16 61
Male 17 33.8 11.5 16 61
Female 04 48.3 5.6 41 54
* Six patients had one benign and one malignant neoplasm. Six patients had intraepithelial neoplasm, not considered here. HIV: human immunodeficiency virus; n: 
number of cases. Mann-Whitney test: total HIV versus HIV with neoplasm p = 0.0176; Student’s t test: HIV male versus HIV with neoplasm male p = 0.3572; HIV 
female versus HIV with neoplasm female p = 0.0221; Mann-Whitney test: HIV with benign neoplasm versus with malignant neoplasm p = 0.1049; male with benign 
neoplasm versus male with malignant neoplasm p = 0.0874; female with benign neoplasm versus female with malignant neoplasm p = 0.0493. 
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relating to the benign type and malignant neoplasias observed, distributed 
by gender and age. There were 39 benign neoplasms in 37 patients, the 
most frequent being 11 hepatic hemangiomas (10 men and one woman) 
and 11 uterine leiomyomas.
Malignant neoplasm was responsible for the death of 18 (6.9%) 
out of 261 total HIV positive patients. The neoplasms relating to 
death were: six KS, four NHL, one HL, one multiple myeloma, two 
gastric adenocarcinoma, one embryonic carcinoma, one hepatocellular 
carcinoma, one intestinal adenocarcinoma and one malignant testicular 
teratoma. Five of these 18 patients had HIV without signs of AIDS: 
one 54-year-old woman with HL, one 26-year-old man with embryonic 
carcinoma, one 52-year-old man with gastric adenocarcinoma, one 
47-year-old woman with intestinal adenocarcinoma and one 26-year-old 
man with malignant testicular teratoma. 
The neoplasms classically considered to be related to AIDS were: four 
cases of primary diffuse large B-cell NHL of the CNS; three men aged 
16, 32 and 48-years-old and one woman aged 41-years-old. NHL was 
not diagnosed in any of the four patients before their deaths. Three other 
lymphoid neoplasias were seen: one HL, one plasmablastic plasmacytoma 
and one multiple myeloma. Six cases of KS with injuries spread amongst 
several organs; all of these patients were male, with ages ranging from 
24 to 61-years-old; three had histories of bi/homosexual activity; five 
involved the digestive tract and only two involved the skin. There were 
no cases of invasive carcinoma of the uterine cervix. However, three 
precursor injuries were found: one CIN I in a 27-year-old patient and 
two CIN II in a 21 and 28-year-old patient. 
Tables 4 and 5 present the frequencies of neoplasms according to 
whether it occurred before or after HAART (introduced in our university 
hospital in 1997). Although a greater number of neoplasms occurred 
in the period after the introduction of HAART (1997 to 2008) with a 
greater number of KS and lymphoid neoplasms, these differences were 
not statistically significant. We also compared the number of patients with 
Table 2
Benign neoplasias in HIV positive patients according to age and sex
Neoplasia n % of total 
HIV 
Age 
(min-max)
Sex 
M:F
Hepatic hemangioma 11 4.2% 24-57 10:1
Uterine leiomyoma 11 15.7%* 34-51 -
Renal adenoma 3 1.2% 33-43 1:2
Renal medullary fibroma 3 1.2% 32-44 3:0
Follicular thyroid adenoma 2 0.8% 41-56 0:2
Lipoma of large bowel 2 0.8% 44-47 2:0
Adrenal adenoma 1 0.4% 38 0:1
Atrial lipoma 1 0.4% 37 1:0
Benign ovarian teratoma 1 1.4%* 38 -
Gastric benign GIST 1 0.4% 40 1:0
Meningioma 1 0.4% 65 1:0
Papilloma of urinary bladder 1 0.4% 34 0:1
Pituitary adenoma 1 0.4% 45 1:0
n: number of cases; min-max: minimum-maximum age; M:F male and female; 
GIST: gastrointestinal stromal tumor. *Calculated according to total 70 woman.
Table 3
Malignant neoplasias in HIV positive patients according to age and sex
Neoplasia n % of total 
HIV 
Age 
(min-max)
Sex 
M:F
Lymphoid neoplasias 7 2.7% 16-54 4:3
Kaposi Sarcoma 6 2.3% 24-61 6:0
Gastric adenocarcinoma 2 0.8% 29-52 2:0
Gastric malignant GIST 1 0.4% 32 1:0
Hepatocarcinoma 1 0.4% 37 1:0
Intestinal adenocarcinoma 1 0.4% 47 0:1
Malignant testicular teratoma 1 0.5%* 26 -
Papillary thyroid carcinoma 1 0.4% 27 1:0
Retroperitoneal embryonal 
carcinoma
1 0.4% 26 1:0
GIST: gastrointestinal stromal tumor; n: number of cases; min-max: minimum-
maximum age; M:F male and female. *Calculated according to total 191 man. Six 
cases of intraepithelial neoplasias (three cervix uterine and three glans tumors) 
were not considered in this table. 
Table 4 
Comparison between the number of cases of HIV with and without neoplasms 
before and after HAART
Neoplasm
Before HAART 
(1989-1996)
After HAART 
(1997-2008)
n % n %
With (n = 58) 13 (15.9%) 45 (25.1%)
Without (n = 203) 69 (84.1%) 134 (74.9%)
Total (n = 261) 82 (100.0%) 179 (100.0%)
Fisher’s exact test p = 0.1096. HAART: highly active antiretroviral therapy; 
n: number of cases.
Table 5 
Comparison between the number of cases of HIV with and without Kaposi 
Sarcoma or lymphoid neoplasms before and after HAART 
Kaposi Sarcoma or 
lymphoid neoplasias
Before HAART 
(1989-1996)
After HAART 
(1997-2008)
n % n %
With (n = 13) 2 (2.4%) 11 (6.2%)
Without (n = 248) 80 (97.6%) 168 (93.8%)
Total (n = 261) 82 (100.0%) 179 (100.0%)
X2 test p = 0.3315. HAART: highly active antiretroviral therapy; n: number of 
cases.
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and without benign and malignant neoplasias before and after HAART 
(Tables 6 and 7), but it was not significant.
DISCUSSION
Most of the studies evaluating necropsies on HIV-positive patients 
involved fewer than 100 necropsias and have described greater 
frequencies of infections than neoplasia. The frequency of neoplasia has 
ranged from 3.3%12 to 28.9%20. We found a relatively high frequency of 
benign and malignant neoplasias (22.2% together) in the present study, 
but if we took into consideration only malignant neoplasias, it’s just 8%. 
The total of 261 HIV patients in our study had a mean age of 35.3 
± 10.7 years, and 73.2% were male. Comparisons with other Brazilian 
studies showed that similar mean ages were found: 33.3 years7 and 34.8 
years12. Studies carried out in developed countries presented mean ages 
slightly greater, of around 38 years20,24,28. This may be because of better 
adherence to treatment, better medical care and longer survival rates. For 
patients with neoplasms, in particular, there is a tendency for older ages 
as in our study20,28. With regards to gender, there are greater numbers of 
males as found in our study7,12,20. 
The neoplasias most frequently found were benign and not related 
to HIV or AIDS until now: hepatic hemangioma (4.2% of HIV patients) 
and uterine leiomyoma (15.7% of HIV-positive women). We did not 
find papers evaluating the frequency of benign neoplasms in patients 
with AIDS or HIV infection, but both neoplasms are frequently found 
among the general population, and their frequencies were within the 
expected range14,25. Following these, the next most frequent tumors 
were lymphoid neoplasias and KS (2.7% and 2.3%, respectively). There 
are studies showing greater prevalence of lymphoid tumors7,12,20,27 and 
others presenting greater frequency of KS1,19,24,28 among HIV-positive 
patients. In our study, these frequencies were similar, as shown by other 
authors23,32. In Brazil, BORGES et al.7 described a frequency of KS that 
was similar to ours (1.9%), while CURY et al.12 did not have any cases 
of this neoplasia. On the other hand, studies in developed countries have 
generally found higher frequencies of KS, such as KLATT et al.24, with 
KS occurring in 24.7% out of 565 necropsies on AIDS patients, and 
MASLIAH et al.28, with KS occurring in 27.1% out of 390 necropsies 
on HIV-positive individuals. 
We found seven cases of lymphoid tumors (2.7% of total HIV); 
there were four NHL (1.5%), all primary of CNS. Studies in the United 
States and Europe have presented greater frequencies of NHL than 
found in Brazilian and African studies. HOFMAN et al.20 in France, 
MARKOWITZ et al.27 in the United States and RIDOLFO et al.32 in Italy 
described frequencies of NHL of 14%, 9.1% and 16.5%, respectively. On 
the other hand, studies carried out in Africa have described frequencies of 
NHL that were closer to ours, although slightly higher, such as LUCAS 
et al.26 with 2.8% and ANSARI et al.1 with 3%. In Brazil, studies have 
described frequencies of NHL that are lower than in the United States and 
Europe, but higher than we found. BORGES et al.7 observed a general 
frequency of lymphoma of 5.8%, consisting of one HL, one pleomorphic 
large T-cell NHL and one centroblastic/centrocytic NHL. The four cases 
of NHL that we described were diffuse large B-cell NHL; three others 
lymphoid neoplasias were seen: one HL, one plasmablastic plasmacytoma 
and one multiple myeloma. CURY et al.12 found two NHL and one HL 
among 92 cases of AIDS (3.3% of lymphoma). We agree with LUCAS et 
al.26 that the difference observed between developed and underdeveloped 
countries in relation to the frequency of neoplasia among AIDS patients is 
associated both with opportunistic infections occurring more frequently 
and the shorter survival rate among patients in underdeveloped countries. 
In an earlier study in which we analyzed the cervicovaginal 
cytological changes in HIV-positive patients29, we found a higher 
frequency of Human Papillomavirus (HPV) infection and low-grade 
intraepithelial squamous injuries in the HIV-positive patients than in 
the HIV-negative patients. However, no such difference was observed 
in relation to high-grade injuries and invasive carcinoma. In the present 
study, the frequency of injuries of the uterine cervix was low: only one 
CIN I and two CIN II, and no cases of invasive carcinoma. Other large 
series of autopsies on AIDS patients have also not described any cases 
of invasive carcinoma of the uterine cervix20,24,27. 
As shown in Table 3, we found other malignant neoplasias than 
those classically described as associated with AIDS. Other authors have 
also found it20,24,27, however, they have concluded that these neoplasias 
were within the expected ranges for that age group among the general 
population. In our study, neoplasias not associated to AIDS until now, 
both benign and malignant, were within the expected range for the 
age group, except for two malignant neoplasias: one diffuse gastric 
adenocarcinoma in a 29-year-old man and one multiple myeloma in a 
28-year-old man. These two neoplasms usually are found in patients 
older than 50-years-old14,25. 
We compared the frequencies of neoplasia in HIV-positive patients 
Table 6 
Comparison between the number of cases of HIV with and without benign 
neoplasias before and after HAART
Benign neoplasias
Before HAART 
(1989-1996)
After HAART 
(1997-2008)
n % n %
With (n = 37) 8 (9.8%) 29 (16.2%)
Without (n = 224) 74 (90.2%) 150 (83.8%)
Total (n = 261) 82 (100.0%) 179 (100.0%)
Fisher’s exact test p = 0.1857. HAART: highly active antiretroviral therapy; 
n: number of cases.
Table 7
Comparison between the number of cases of HIV with and without malignant 
neoplasias before and after HAART
Malignant neoplasias
Before HAART 
(1989-1996)
After HAART 
(1997-2008)
n % n %
With (n = 21) 4 (4.9%) 17 (9.5%)
Without (n = 240) 78 (95.1%) 162 (90.5%)
Total (n = 261) 82 (100.0%) 179 (100.0%)
Fisher’s exact test p = 0.2316. HAART: highly active antiretroviral therapy; 
n: number of cases.
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according to the introduction of HAART. Although there were greater 
numbers of neoplasia after HAART than before (25.1% versus 15.9%, 
respectively) and also greater numbers of KS and lymphoid neoplasias 
(6.2% versus 2.4%, respectively), these differences were not statistically 
significant. Three other studies4,20,24 also observed an increased frequency 
of neoplasia among AIDS patients following the introduction of HAART, 
mainly because of increases in the numbers of NHL and carcinoma. 
On the other hand, MASLIAH et al.28 did not observe any change 
in the frequency of neoplasia occurrence among AIDS patients after 
the introduction of HAART. We also observed higher frequencies of 
benign neoplasias (16.2% versus 9.8%, respectively) and malignant 
neoplasias (9.5% versus 4.9%, respectively) after HAART, although it 
was not significant. It could be because of the small number of cases 
in each group; it is important to also note that we separated the groups 
according to the date of the necropsy, usually the same as the diagnosis 
of the tumor, for both malignant and benign neoplasms, but that could 
influence in the results.
We therefore conclude that the types of neoplasia most frequently 
found in necropsies on HIV-positive patients in our study were KS and 
NHL, which are considered to be associated with AIDS. Other frequently 
found neoplasia types, particularly hepatic hemangioma and uterine 
leiomyoma, did not appear to be associated with HIV infection, since 
they occurred at the same frequency as observed among the general 
population. Finally, the introduction of HAART into our environment 
does not appear, so far, to have increased the frequency of neoplasia 
among HIV-positive patients.
RESUMO
Neoplasias benignas e malignas em 261 necropsias de pacientes 
HIV positivos no período de 1989 a 2008
Tendo em vista que trabalhos sobre necropsias de AIDS analisam 
apenas neoplasias malignas e que ocorreram alterações após a terapia 
antiretroviral altamente eficaz (HAART), este estudo foi feito com 
objetivo de avaliar a frequência de neoplasias benignas e malignas nos 
períodos pré e pós-HAART. Estudo retrospectivo de 261 necropsias de 
HIV positivos entre 1989 e 2008 em Uberaba - Brasil. Foram encontradas 
66 neoplasias (39 benignas, 21 malignas e seis lesões pré-invasivas) em 
58 pacientes. As neoplasias malignas mais frequentes foram linfóides, em 
2,7% (quatro linfomas não Hodgkin, um Hodgkin, um mieloma múltiplo 
e um plasmocitoma plasmoblástico) e, sarcoma de Kaposi, em 2,3% (seis 
casos). As benignas mais frequentes foram hemangiomas hepáticos em 
11 (4,2%) dos 261 casos e leiomiomas uterinos em 11 (15,7%) das 70 
mulheres. No período pré-HAART ocorreram oito (9,8%) neoplasias 
benignas e quatro (4,9%) malignas em 82 pacientes; no pós-HAART, 
29 (16,2%) benignas e 17 (9,5%) malignas; entretanto, essas diferenças 
não foram estatisticamente significantes. Concluímos que a introdução 
da HAART em nossa região não parece ainda ter alterado a frequência 
de neoplasias em pacientes HIV. 
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